The Relationship of Medication Adherence to Controlled HbA1c and ASCVD Risk in Type II Diabetes Mellitus Patients in Minggir Primary Health Care

Aquina Nino Rama Dhanti Dewita; Phebe Hendra; Dita Maria Virginia

doi:10.24071/jpsc.007464

The Relationship of Medication Adherence to Controlled HbA1c and ASCVD Risk in Type II Diabetes Mellitus Patients in Minggir Primary Health Care

Aquina Nino Rama Dhanti Dewita^(1*), Phebe Hendra⁽²⁾, Dita Maria Virginia⁽³⁾,

(1) Sanata Dharma University
(2) Sanata Dharma University,
(3) Sanata Dharma University,
(*) Corresponding Author

Abstract

Type II diabetes mellitus (DM) therapy can be evaluated from the controlled HbA1c. Another aspect that needs to be controlled in patients with DM is lipid levels. Lipid levels should be controlled in a patient with type II DM to prevent atherosclerotic cardiovascular disease (ASCVD). The study was conducted to determine the relationship between medication adherence with controlled HbA1c and ASCVD risk in patients with type II DM. The study was an analytical observational study with a cross-sectional research design used to examine the relationship between medication adherence with controlled HbA1c and ASCVD risk. Our respondents were patients following a chronic disease management program at Minggir Primary Health Care. The level of medication adherence was measured using the Medication Adherence Report questionnaires. The ASCVD risk was measured using the American College of Cardiology/American Heart Association tools. The chi-squared test was applied to determine the relationship between medication adherence with HbA1c values and ASCVD risk in patients with type II DM. Most patients with type II DM had high medication adherence (60%), controlled HbA1c values (56.4%), and high ASCVD risk (70.9%). There was no significant relationship between medication adherence in type II DM patients with controlled HbA1c values and ASCVD risk.

Keywords

Adherence; ASCVD; HbA1c; Medication; Type II DM

Full Text:

PDF

References

Adikusuma, W, and Nurul, Q. 2017. Hubungan tingkat kepatuhan minum obat antidiabetik oral terhadap kadar hemoglobin terglikasi (Hba 1 C) pada pasien diabetes melitus tipe 2. Jurnal Ilmiah Ibnu Sina, 2(2), 279–286.

Adikusuma, W., Perwitasari, D. A., and Supadmi, W. 2014. Evaluation of type 2 diabetes mellitus patient adherence in PKU Muhammadiyah Hospital of Bantul, Yogyakarta. Media Farmasi, 11(2), 208–220.

Akrom A., Sari, O. M., Urbayatun, S., and Saputri, Z. 2019. Analisis determinan faktor-faktor yang berhubungan dengan kepatuhan minum obat pasien diabetes tipe 2 di Pelayanan Kesehatan Primer. Jurnal Sains Farmasi and Klinis, 6(1), 54.

Alfian, R. 2015. Korelasi antara kepatuhan minum obat dengan kadar gula darah pada pasien diabetes melitus rawat jalan di RSUD Dr. H. Moch. Ansari Saleh Banjarmasin. Jurnal Pharmascience, 2(2), 15–23.

Alfian, R., Maulana, A., and Putra, P. 2017. Uji Validitas dan reliabilitas kuesioner Medication Adherence Report Scale (MARS) terhadap pasien diabetes mellitus. Jurnal Ilmiah Ibnu Sina, 2(2), 176–183.

Aljufri, Q. A. 2020. Review artikel: Pengaruh terapi statin terhadap risiko Atherosclerotic Cardiovascular Disease (ASCVD). Media Farmasi Indonesia, 18(1), 55–62.

Anharudin, Tejamaya, M., D. 2022. Perbandingan risiko kardiovaskuler menggunakan metode Framingham, WHO chart dan ASCVD pada pekerja PT. X Tahun 2021. Jurnal Kesehatan Masyarakat, 12(01), 77–84.

Bertoluci, M. C., and Rocha, V. Z. 2017. Cardiovascular risk assessment in patients with diabetes. Diabetology and Metabolic Syndrome, 9(1).

Chan, A. H. Y., Horne, R., Hankins, M., and Chisari, C. 2020. The Medication Adherence Report Scale: A measurement tool for eliciting patients’ reports of nonadherence. British Journal of Clinical Pharmacology, 86(7), 1281–1288.

Almasdy, D., Sari, D. P., Suharti, Darwin, D., and Kurniasih, N. 2015. Evaluasi penggunaan obat antidiabetik pada pasien diabetes melitus tipe-2 di suatu Rumah Sakit Pemerintah Kota Padang - Sumatera Barat. Jurnal Sains Farmasi and Klinis, 2(1), 104–110.

Dwivani, C., Harijadi, K., and Suhadi, R. 2018. Perbandingan lima metode estimasi risiko 10 tahun penyakit kardiovaskuler pada masyarakat Kabupaten Sleman-Yogyakarta [Comparison of Five Methods of 10 Years Cardiovascular Disease Risk Estimation Among Community in Sleman-Yogyakarta]. JMPF, 8(2), 59–69.

Eka, M., Yulianti, P., Pranatawai, I. 2016. Hubungan profil lipid dengan diabetes mellitus tipe 2 pada usia dewasa di Klinik Medistra Bengkulu. Jurnal Kedokteran Raflesia, 2(2), 85–89.

Firdiawan, A., Andayani, T. M., and Kristina, S. A. 2021. Hubungan kepatuhan pengobatan terhadap outcome klinik pasien diabetes melitus tipe 2 dengan Medication Adherence Rating Scale-5 (MARS-5). Majalah Farmaseutik, 17(1), 22.

Gumantara B P M, and Oktarlina, R., Z. 2017. Perbandingan monoterapi dan kombinasi terapi sulfonilurea-metformin terhadap pasien diabetes mellitus tipe 2. Majority, 6(1), 55–59.

Husni, M., Lapau, B., Hardhana, B. V. 2018. Relationship of dislipidemia and diabetes mellitus with coroner heart disease events in general hospital. Caring Nursing Journal, 2(2), 2580–0078.

Indonesia Ministry of Health. 2020. Infodatin 2020 Diabetes Melitus: Tetap Produktif, Cegah, dan Atasi DM. Indonesia Ministry of Health. Indonesia Ministry of Health. 2020. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Diabetes Melitus Tipe 2 Dewasa. In Keputusan Menteri Kesehatan RI (pp. 32–74).

Indonesia Ministry of Health and Health Research and Development Center. 2019. Laporan Nasional RISKESDAS 2018. BALITBANGKES. International Diabetes Federation. 2019.

IDF Diabetes ATLAS 9th edition. International Diabetes Federation. 2021. IDF Diabetes Atlas 10th edition.

Karimah, H. N., Sarihati, I. G. A. D., and Habibah, N. 2018. Gambaran kadar HbA1c pada pasien diabetes melitus tipe 2 di RSUD Wangaya. Meditory, 6(2), 88–98.

Kozakiewicz, K., Podolecka, E., Syzdól, M., Piwoński, J., Bielecki, W., and Pajak, A. 2016. Relationship between education and cardiovascular risk score. Polskie Archiwum Medycyny Wewnetrznej, 126(5), 369–371.

Latifatunnisa, I., Mulyanto, B., and Hidayat Maulana, L. 2023. The relationship of compliance with taking oral antidiabetic drugs to HbA1c values in type II diabetes mellitus patients in the outpatient installation of Muhammadiyah Sita Aminah Bumiayu Hospital in 2022. Pharmacy Peradaban Journal, 3(1), 40–60.

Mulyani, R. 2016. Hubungan Kepatuhan dengan Keberhasilan Terapi Berbasis Kombinasi Insuli dan Obat Antidiabetik Oral Pada Pasien Diabetes Melitus Tipe 2 di Instalasi Rawat Jalan Rumah Sakit Umum Daerah Ulin Banjarmasin. In Prosiding Rakernas dan Pertemuan Ilmiah Tahunan Ikatan Apoteker Indonesia.

Naufanesa, Q., Nurhasnah, Nurfadila, S., and Ekaputri, N. W. 2020. Compliance with medicines and quality of life of diabetes mellitus patients at Islamic Hospital, Jakarta. Media Farmasi, 17(2), 60–71.

Ningrum, D. K. 2020. Kepatuhan minum obat pada penderita diabetes melitus tipe II. Higeia: Journal of Public Health Research and Development, 4(3), 492–505. Novian, A. 2013. Kepatuhan diit pasien hipertensi. Jurnal Kesehatan Masyarakat, 9(1), 100–105.

Perkumpulan Endokrinologi Indonesia. 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2021.

S.-E. F. F. Dr. dr. Soebagijo Adi Soelistijo. PB. PERKENI. Perkumpulan Endokrinologi Indonesia. 2021. Pedoman Pengelolaan Dislipidemia Di Indonesia 2021. Andi Makbul Aman, D. M. PB PERKENI.

Perwitasari, D. A., Dania, H., Faridah, I. N., and Irham, L. M. 2022. Impact of adherence on treatment outcomes in diabetic patients. The International Conference of Medicine and Health, 2, 183–189.

Pradana, I. P. A. 2015. Hubungan karakterisktik pasien dengan tingkat kepatuhan dalam menjalani terapi diabetes melitus di Puskesmas Tembuku 1 Kabupaten Bangli Bali 2015. Intisari Sains Medis, 8(1), 1–5.

Pramana, A. G., Setia Dianingati, R., and Eka Saputri, N. 2019. Faktor-faktor yang mempengaruhi kepatuhan minum obat pasien hipertensi peserta Prolanis di Puskesmas Pringapus Kabupaten Semarang. Indonesian Journal of Pharmacy and Natural Products, 2(1), 52–58.

Pramestutie, H. R., Sari, M. P., and Illahi, R. K. 2016. Tingkat pengetahuan pasien diabetes mellitus tentang penggunaan obat di Puskesmas Kota Malang. Pharmaceutical Journal of Indonesia, 2(1), 7–11.

Public Health Office for Sleman Regency. 2020. Profil Kesehatan Kabupaten Sleman Tahun 2020.

Puspaseruni, K. 2021. Tatalaksana dislipidemia terkait Penyakit Kardiovaskular Aterosklerosis (ASCVD): Fokus pada penurunan LDL-c. Continuing Medical Education, 48(10), 395–401.

Radito. 2014. Analisis pengaruh kualitas pelayanan dan fasilitas kesehatan terhadap kepuasan pasien Puskesmas. Jurnal Ilmu Manajemen, 11(2), 1–26.

Rwegerera, G. M. 2014. Adherence to anti-diabetic drugs among patients with type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study. The Pan African Medical Journal, 17, 252.

Sankar, V., Justin, A., Payman, H. M., Swathy, P., Sai Charan Kumar, N., and Senthil Kumar, R. 2018. Medication adherence and clinical outcomes in type 2 diabetes mellitus patients with depression: A prospective interventional study. Marmara Pharmaceutical Journal, 22(4), 599–606.

Siwi, M. A. A., Ilmanita, D., and Dias, M. S. C. 2022. Tingkat kepatuhan penggunaan obat antidiabetes oral pada pasien DM di Rumah Sakit Bantuan Rampal Malang. Jurnal Kefarmasian dan Gizi, 1(2), 47–57.

Soraya, I. A., Sauriasari, R., Prawiroharjo, P., and Risni, H. W. 2022. The association between adherence to oral antihyperglycemic agent and HbA1c level. Pharmaceutical Sciences and Research, 9(2), 93–101.

Wakabayashi, I. 2017. Gender differences in cardiovascular risk factors in patients with coronary artery disease and those with type 2 diabetes. Journal of Thoracic Disease, 9(5), E503–E506.

Wibowo, M. I N, A., Fitri, F. M., Yasin, N. M., Kristina, S. A., and Prabandari, Y. S. 2021. Medication adherence in patients with type 2 diabetes in several health centers of Banyumas District. Jurnal Kefarmasian Indonesia, 11(2), 98–108.

Yulianti, T., and Anggraini, L. 2020. Factors affecting medication adherence in outpatient diabetes mellitus at RSUD Sukoharjo. Jurnal Farmasi Indonesia, 17(2), 110–120.

ZA, M. Abrar Naufal. H., et al. 2022. Hubungan antara dislipidemia dengan diabetes melitus tipe 2 di Rumah Sakit Ibnu Sina Makassar. Fakumi Medical Journal, 2(9), 668–677.

DOI: https://doi.org/10.24071/jpsc.007464